These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8628354)

  • 1. Parkinsonism and Parkinson's disease.
    Weiner WJ; Singer C; Shulman LM
    N Engl J Med; 1996 Jun; 334(24):1611. PubMed ID: 8628354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular Parkinson syndromes: a controversial concept].
    Fénelon G; Houéto JL
    Rev Neurol (Paris); 1998 May; 154(4):291-302. PubMed ID: 9773057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.
    Schrag A; Ben-Shlomo Y; Brown R; Marsden CD; Quinn N
    Mov Disord; 1998 Nov; 13(6):885-94. PubMed ID: 9827611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
    Goldsmith JR; Herishanu YO; Podgaietski M; Kordysh E
    Environ Res; 1997; 73(1-2):156-61. PubMed ID: 9311541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study).
    Barbosa MT; Caramelli P; Maia DP; Cunningham MC; Guerra HL; Lima-Costa MF; Cardoso F
    Mov Disord; 2006 Jun; 21(6):800-8. PubMed ID: 16482566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does fluoxetine exacerbate Parkinson's disease?
    Caley CF; Friedman JH
    J Clin Psychiatry; 1992 Aug; 53(8):278-82. PubMed ID: 1500404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatosensory evoked potentials in Parkinson's disease and vascular parkinsonism].
    Tachibana H; Takeda M; Narita M; Sugita M; Kondo J; Miyauchi M; Mimura K; Matsuoka A
    Rinsho Byori; 1987 Jun; 35(6):698-702. PubMed ID: 3669380
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral and genital pain syndromes in Parkinson's disease.
    Ford B; Louis ED; Greene P; Fahn S
    Mov Disord; 1996 Jul; 11(4):421-6. PubMed ID: 8813222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.
    Ghosh B; Mishra A; Sengupta P
    J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.
    Bergareche A; De La Puente E; López de Munain A; Sarasqueta C; de Arce A; Poza JJ; Martí-Massó JF
    J Neurol; 2004 Mar; 251(3):340-5. PubMed ID: 15015016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do autonomic function tests in people with Parkinson's disease predict survival rates at 7 years follow-up?
    Gray WK; Wood BH; Walker RW
    Mov Disord; 2009 Dec; 24(16):2432-4. PubMed ID: 19890986
    [No Abstract]   [Full Text] [Related]  

  • 12. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data.
    Swarztrauber K; Anau J; Peters D
    Mov Disord; 2005 Aug; 20(8):964-70. PubMed ID: 15834854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of Parkinson's disease.
    Cohen MM; Scheife RT
    Am J Hosp Pharm; 1977 May; 34(5):531-8. PubMed ID: 326045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia.
    Silberstein P; Kühn AA; Kupsch A; Trottenberg T; Krauss JK; Wöhrle JC; Mazzone P; Insola A; Di Lazzaro V; Oliviero A; Aziz T; Brown P
    Brain; 2003 Dec; 126(Pt 12):2597-608. PubMed ID: 12937079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: progression and mortality in the L-DOPA era.
    Di Rocco A; Molinari SP; Kollmeier B; Yahr MD
    Adv Neurol; 1996; 69():3-11. PubMed ID: 8615142
    [No Abstract]   [Full Text] [Related]  

  • 17. Minor depression and brain perfusion images in Parkinson's disease.
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimation in Parkinson's disease.
    Bagheri H; Berlan M; Senard JM; Rascol O; Montastruc JL
    Clin Neuropharmacol; 1994 Feb; 17(1):89-91. PubMed ID: 8149363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between weight loss and dysphagia in patients with Parkinson's disease].
    Nozaki S; Saito T; Matsumura T; Miyai I; Kang J
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1010-4. PubMed ID: 10655760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.